AVIPERO Bio Revenue

Biotechnology Research • Wilmington, Delaware, United States • 1-10 Employees

AVIPERO Bio revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at AVIPERO Bio

Rehab Aljamal-Naylor

Chief Executive Officer

Company overview

Headquarters	Wilmington, Delaware, United States
Phone number	+19803641010
Website	avipero.com
NAICS	541714
Founded	2023
Employees	1-10

About AVIPERO Bio

DEVELOPING UNIQUE Allosteric modulators of integrins for cancer: The dimmer switch analogy AVIPERO has unique Platform technology with multiple applications/indications. AVIPERO Bio is led by strong team with track record in drug development in cancer. At Avipero we aspire to revolutionize the treatment of malignant and degenerative diseases worldwide. We are dedicated to the study of advanced cancer, our pharmaceutical research company prioritizes the development of a non-destructive cure for this metastatic disease.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

AVIPERO Bio has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

AVIPERO Bio has never raised funding before.

Frequently asked questions

AVIPERO Bio is located in Wilmington, Delaware, US.

You can reach AVIPERO Bio at +19803641010.

AVIPERO Bio generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

AVIPERO Bio has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

AVIPERO Bio was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

AVIPERO Bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at AVIPERO Bio

Rehab Aljamal-Naylor

Chief Executive Officer

4.8

40,000 users